Tarceva erlotinib regulatory update

FDA's Oncologic Drugs Advisory Committee voted 10-3 to recommend approval of an sNDA for Tarceva erlotinib to treat advanced or metastatic pancreatic carcinoma in combination with gemcitabine. The com...